Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04374708 · ClinicalTrials.gov registry record
Gender Identity and Own Body Perception
A clinical trial, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- 132
- Enrollment target
NCT04374708: Clinical Trial study, sponsored by University of California, Los Angeles.
NCT04374708 is a clinical trial that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04374708 was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- 132 participants
- Enrollment target
Study Summary
This study will provide valuable information on the neurobiological underpinning of gender dysphoria (GD) and the effects of sex hormones, and promises to uncover functional or structural neural patterns that could predict outcome in terms of body image and quality of life after cross-sex hormone treatment.
Primary Outcome
Own body perception in relation to functional and structural connection
Interventions
- DIAGNOSTIC_TEST fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2018-02-22 |
| Est. Completion | 2021-12-31 |
Why NCT04374708 stopped before completion
NCT04374708 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT04374708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04374708 about?
NCT04374708 is a clinical study titled "Gender Identity and Own Body Perception". This study will provide valuable information on the neurobiological underpinning of gender dysphoria (GD) and the effects of sex hormones, and promises to uncover functional or structural neural patterns that could predict outcome in terms of body image and quality of life after cross-sex hormone tr...
What is the current status of trial NCT04374708?
This trial is currently terminated. The enrollment target is 132 participants. The study started on 2018-02-22. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04374708?
The interventions under investigation include: fMRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04374708?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI